Crimean-Congo hemorrhagic fever: Difference between revisions

(Text replacement - "==Diagnostic Evaluation==" to "==Evaluation==")
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==Background==
==Background==
*A tick-borne virus (Nairovirus) in the Bunyavirus family
*Caused by tick-borne virus (Nairovirus) in the Bunyavirus family
*Regions: Eastern Europe, Mediterranean, NW China, central Asia, southern Europe, Africa, Middle East, Indian subcontinent
*Ixodid ticks are reservoir and vector; direct transmission via body fluids
*First described in the Crimea and later in the Congo
*First described in the Crimea and later in the Congo
*Affected regions: Eastern Europe, Mediterranean, NW China, central Asia, southern Europe, Africa, Middle East, Indian subcontinent
*Ixodid ticks are reservoir and vector
*Direct human-human transmission via body fluids


==Clinical Features==
==Clinical Features==
Line 24: Line 25:
{{Fever in Traveler DDX}}
{{Fever in Traveler DDX}}


==Diagnosis==
==Evaluation==
'''Labs''':
*Antigen-capture ELISA
*Antigen-capture ELISA
*RT-PCR
*RT-PCR
*Virus isolation
*Virus isolation
*Antibody ELISA
*Antibody ELISA
'''Imaging''':
None


==Management==
==Management==
*Supportive
*Supportive care
*IV/PO Ribavirin
*IV/PO Ribavirin


==Disposition==
==Disposition==
Admission
*Admit


==See Also==
==See Also==
[[Viral hemorrhagic fevers]]
*[[Viral hemorrhagic fevers]]


==Category==
==External Links==
[[Infectious Disease]]
*[http://www.cdc.gov/vhf/crimean-congo/ CDC Crimean-Congo Hemorrhagic Fever]


==References==
==References==
*Crimean-Congo Hemorrhagic Fever (CCHF). www.cdc.gov. [http://www.cdc.gov/vhf/crimean-congo/]. Updated [5/9/15].
<references/>
*Crimean-Congo Hemorrhagic Fever (CCHF). World Health Organization Fact Sheet. [http://www.who.int/mediacentre/factsheets/fs208/en/].
<references/>
*Rosen's Emergency Medicine. 8e. 2013.
<references/>
<references/>
[[Category:ID]]
[[Category:Tropical Medicine]]

Latest revision as of 04:03, 28 July 2016

Background

  • Caused by tick-borne virus (Nairovirus) in the Bunyavirus family
  • First described in the Crimea and later in the Congo
  • Affected regions: Eastern Europe, Mediterranean, NW China, central Asia, southern Europe, Africa, Middle East, Indian subcontinent
  • Ixodid ticks are reservoir and vector
  • Direct human-human transmission via body fluids

Clinical Features

History:

  • Exposure risk factors: animal herders, livestock workers, slaughterhouse workers, and healthcare workers in endemic areas
  • Incubation period usually lasts less than one week from exposure
  • Sudden onset of: headache, high fever, back/joint/stomach pain, vomiting, photophobia
  • Mood swing and confusion develop after initial symptoms, followed by sleepiness and depression.
  • Abdominal pain migrates to RUQ

Physical Exam:

  • Conjunctivitis, facial flushing, palatal erythema and petechiae, lymphadenopathy,
  • Jaundice and changes in mood and sensory perception
  • Signs of coagulopathy (starting around day 4)
  • Palpable hepatomegaly

Clinical Course: Estimated 9-50% mortality

Differential Diagnosis

Fever in traveler

Evaluation

  • Antigen-capture ELISA
  • RT-PCR
  • Virus isolation
  • Antibody ELISA

Management

  • Supportive care
  • IV/PO Ribavirin

Disposition

  • Admit

See Also

External Links

References